Related Experiment Video
Updated: Jul 5, 2026
10:10
Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
Published on: October 27, 2009
Epinephrine augments von Willebrand factor-dependent shear-induced platelet aggregation
1Cardiopulmonary Division, School of Medicine, Keio University, Tokyo, Japan.
Circulation
|December 1, 1992
Summary
Epinephrine enhances shear-induced platelet aggregation (SIPA) via von Willebrand factor (vWF) under high shear conditions. This interaction is critical for understanding blood clot formation in stenosed arteries.
Area of Science:
- Hematology
- Biophysics
Background:
- Shear-induced platelet aggregation (SIPA) is a key factor in blood clot formation (thrombogenesis).
- von Willebrand factor (vWF) binding to platelet glycoprotein Ib (GP Ib) is essential for platelet aggregation under high shear forces, such as those found in narrowed arteries.
Purpose of the Study:
- To clarify the physiological significance of vWF-dependent SIPA.
- To investigate the role of agonists like epinephrine, ADP, and collagen in SIPA under varying shear conditions.
Main Methods:
- Blood samples from 23 healthy volunteers were analyzed.
- SIPA was monitored using a modified cone-plate viscometer measuring light transmission.
- The effects of epinephrine, ADP, and collagen on SIPA were tested at low (12 dyne/cm²) and high (108 dyne/cm²) shear forces.
Main Results:
- Epinephrine, ADP, and collagen enhanced SIPA at low shear.
- Only epinephrine augmented SIPA at high shear, increasing aggregation from 37.9% to 59.7%.
- An alpha 2-adrenergic receptor antagonist (yohimbine) blocked epinephrine's effect; an anti-vWF antibody (NMC-4) abolished high-shear SIPA.
Conclusions:
- Epinephrine acts as the primary agonist enhancing vWF-mediated SIPA via its specific receptor.
- This mechanism is clinically relevant, as coronary artery occlusion often occurs in atherosclerotic vessels during sympathetic stimulation.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.